Thoratec Announces Presentations At Investor Conferences For June 2014

    Thoratec Announces Presentations At Investor Conferences For June 2014

PR Newswire

PLEASANTON, Calif., June 3, 2014

PLEASANTON, Calif., June 3, 2014 /PRNewswire/ --Thoratec Corporation (NASDAQ:
THOR), a world leader in device-based mechanical circulatory support therapies
to save, support and restore failing hearts, said today it will be
participating in three upcoming investor conferences.

On Tuesday, June 10, the company will participate in the Goldman Sachs 35^th
Annual Global Healthcare Conference. Gary F. Burbach, President and Chief
Executive Officer, will provide an update on the company, beginning at 1:20
p.m., Pacific Daylight Time (4:20 p.m., Eastern Daylight Time). A webcast of
the presentation will be available at
http://cc.talkpoint.com/gold006/061014a_an/?entity=8_KGWVILU, or on the
company's website at http://www.thoratec.com.

On Wednesday, June 11, Thoratec will participate in the William Blair 34^th
Annual Growth Stock Conference. The presentation by Taylor C. Harris, Vice
President and Chief Financial Officer, will begin at 4:40 p.m., Central
Daylight Time (5:40 p.m., Eastern Daylight Time). A webcast of the
presentation will be available at http://wsw.com/webcast/blair48/thor, or on
the company's website at http://www.thoratec.com.

On Wednesday, June 18, Thoratec will participate in the 2014 Wells Fargo
Healthcare Conference. The presentation by Taylor C. Harris, Vice President
and Chief Financial Officer, will begin at 8:55 a.m., Eastern Daylight Time
(5:55 a.m., Pacific Daylight Time). A webcast of the presentation will be
available at http://cc.talkpoint.com/well001/061714a_ac/?entity=4_DW01W53, or
on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered
trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec
Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC,
and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Neil Meyer, Director of Investor Relations, Thoratec Corporation,
(925) 738-0029
 
Press spacebar to pause and continue. Press esc to stop.